Biological variation of N-terminal pro-brain natriuretic peptide in healthy individuals [3]

Clinical Chemistry

Volumn 49, Issue 9, 2003, Pages 1554-1555

  Melzi d'Eril, GianVico ^a   Tagnochetti, Tiziana ^b   Nauti, Andrea ^b   Klersy, Catherine ^c   Papalia, Antonia ^d   Vadacca, Giovanbattista ^d   Moratti, Remigio ^d   Merlini, Giampaolo ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR;

ADULT; AMINO TERMINAL SEQUENCE; BIOLOGICAL RHYTHM; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; INDIVIDUALIZATION; LETTER; MALE; NORMAL HUMAN;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; REFERENCE VALUES;

EID: 0041942556     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.9.1554     Document Type: Letter

References (5)

1. Clerico A. Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease? Clin Chem Lab Med 2002;40:752-60.
2. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, et al. Utility of B-natriuretic peptide levels in identifying patients With left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-9.
3. Tabbibizar R, Maisel A. The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure [Review]. Curr Opin Cardiol 2002;17:340-5.
4. Fraser CG. Biological variation: from principles to practice. Washington: AACC Press, 2001: 151pp.
5. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997;47:287-96.